Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
MrktWatch
 
about-us our-services Trading-account ETrade MF IPO Research Fundamentals charts Market Watch News

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Profit and Loss
Glenmark Pharmaceuticals Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs & Formln  Chairman  : Glenn Saldanha
    Home        : Indian Private  Book Value: 855.7128074
    BSE Code  : 532296  Market Cap: 73176.62
    NSE Code  : GLENMARK  P / E              : 50.12 

Change Company :
(Rs in Cr.)
Profit and Loss
ParticularsMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Sales Turnover & Other Income 9212.129582.7814129.489206.609186.54
Excise Duty0.000.000.000.000.00
Total Income9317.549538.3014232.559237.979202.67
Raw Materials 3184.373154.653313.193427.073425.06
Stock Adjustments 105.42-44.48103.0731.3716.13
Other Manufacturing Expenses 370.83372.36375.32304.66347.04
Power & Fuel Cost112.65114.62104.9295.0991.34
Employee Cost 1790.411603.501434.781346.511193.20
Selling and Administration Expenses 1593.611305.301199.171246.101062.89
Miscellaneous Expenses 2217.11566.49325.15855.71349.97
Less: Preoperative Expenditure Capitalised0.000.000.000.000.00
Profit before Interest, Depreciation & Tax48.572421.387480.021962.852733.19
Interest & Financial Charges 78.7548.73277.11206.82236.04
Profit before Depreciation & Tax-30.182372.657202.911756.032497.15
Depreciation235.89218.63202.16184.15159.70
Profit Before Tax-266.072154.027000.751571.882337.45
Tax-65.27543.671833.46363.11339.66
Profit After Tax-200.801610.355167.291208.771997.79
Adjustment below Net Profit -16.96-6.47-4.760.631.61
P & L Balance brought forward22581.1521088.1316002.8214863.9612921.86
Appropriations 266.25110.8777.2270.5457.30
P & L Bal. carried down22097.1522581.1521088.1316002.8214863.96
Equity Dividend141.1070.5570.5470.5470.54
Preference Dividend0.000.000.000.000.00
Corporate Dividend Tax0.000.000.000.000.00
Equity Dividend (%)500.00250.00250.00250.00250.00
Earning Per Share (Rs.)-7.1257.07183.1142.8470.80
Book Value855.79868.35814.01633.57593.21
Extraordinary Items -1143.27-152.913742.26-369.56354.02
Top
BSE Disclaimer     |     Disclaimer     |     RA Disclosures and Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   ODR Circular   |   Attention Investors   | RA - Auditor Report 2025-2026   | RA – Annual Compliance Audit Report 2025-26   | RA – ATR   | UPI IDs for Payment

SEBI Saa₹thi Mobile App/SEBI Investor Website  

BSE Delayed data sourced at 5 mins : www.bseindia.com | NSE Delayed data sourced at 15 mins : www.nseindia.com
SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
Research Analyst SEBI Reg. No.INH000001527 | Research Analyst BSE Enlistment Number: 5104
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Designed, Developed, Maintained and Content Powered by
C-MOTS InfoTech(ISO 9001:2015 & ISO/IEC 27001:2022 Certified)
Charts are powered by TradingView